Novartis Institutes for BioMedical Research Global Scholars Program 2021

Novartis Institutes for BioMedical Research (NIBR) have invited Boston University, as one of a select group of international institutions, to participate in their NIBR Global Scholars Program 2021 (Kerberos log-in required). The program will provide BU faculty investigators with access to disease area drug-hunting and translational research expertise. Selected proposals, not funded by traditional grant support, will receive up to $1 million over three years.

Initial two-page, non-confidential pre-proposals must be submitted for review by BU Industry Engagement and Technology Development by Monday, May 10, prior to the NIBR submission (deadline of Friday, May 14). Pre-proposals should be submitted for review using a web form on the Industry Engagement website (Kerberos log-in required).

    Proposals focused in any of the following areas are encouraged:

    Disease Areas

    • Autoimmunity, Transplantation & Inflammation
    • Cardiovascular and Metabolic
    • Immuno-Oncology
    • Musculoskeletal Diseases
    • Neurosciences
    • Oncology
    • Ophthalmology
    • Tropical Diseases
    • Additional Disease Areas

    Platform Technologies

    • Analytical Sciences & Imaging
    • Biologics
    • Cell and Gene Therapy
    • Chemical and Biological Therapies
    • Discovery Chemistry
    • PK Sciences and Preclinical Safety

    Download the full list of scientific needs on the program webpage.

    Information For...